Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2 …

S Sridhar, A Joaquin, MI Bonaparte… - The Lancet Infectious …, 2022 - thelancet.com
Background We evaluated our SARS-CoV-2 prefusion spike recombinant protein vaccine (CoV2
preS dTM) with different adjuvants, unadjuvanted, and in a one-injection and two-…

Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines …

…, K Hudzina, M Hutchens, PGJ Booth, A Joaquin… - …, 2023 - thelancet.com
Background In a parallel-group, international, phase 3 study (ClinicalTrials.gov NCT04762680),
we evaluated prototype (D614) and Beta (B.1.351) variant recombinant spike protein …

Functional decline in aging and disease: a role for apoptosis

AM Joaquin, S Gollapudi - Journal of the American Geriatrics …, 2001 - Wiley Online Library
The process of aging and senescence is associated with a decline in several organ functions
and ultimately takes away independence and reduces quality of life. The precariously …

Safety and immunogenicity of a SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in healthy adults: interim findings from a phase 2, randomised, dose …

S Sridhar, A Joaquin, MI Bonaparte, A Bueso… - medRxiv, 2021 - medrxiv.org
Background This study evaluated the safety and immunogenicity of an AS03-adjuvanted
SARS-CoV-2 recombinant protein candidate vaccine, CoV2 preS dTM. Methods This Phase 2, …

Efficacy of Messenger RNA–1273 Against Severe Acute Respiratory Syndrome Coronavirus 2 Acquisition in Young Adults From March to December 2021

…, RN Greenberg, A Joaquin… - Open Forum …, 2023 - academic.oup.com
Background The efficacy of messenger RNA (mRNA)–1273 against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection is not well defined, particularly among …

Evaluation of infections in long-term care facilities versus acute care hospitals

AM Joaquin - Infection management for geriatrics in long-term …, 2006 - taylorfrancis.com
Long-term care facilities (LTCFs) include nursing homes (NH), assistedliving facilities, and
other facilities where chronic care is provided to residents. This chapter will mainly focus on …

[CITATION][C] Megestrol acetate suspension therapy in the treatment of geriatric anorexia/cachexia in nursing home patients

S Castle, C Nguyen, A Joaquin, B Coyne… - Journal of the …, 1995 - Wiley Online Library
To the Editor: Weight-loss and protein-energy malnutrition are conditions found in 20 to 30%
of frail older adults.’This syndrome, called anorexia of aging, is likely attributable to multiple …

Hypothermia and Hyperthermia

AM Joaquin - Acute Emergencies and Critical Care of the Geriatric …, 2000 - taylorfrancis.com
One of the earliest problems that confronted man was survival and protection against the
extreme ranges of environmental temperatures. Although lower forms of animals, such as the …

[PDF][PDF] HANDOUT; Case Studies Please read before the webinar session.

A Joaquin, MDM McBride - sgec.stanford.edu
Mrs. RA came to the US in her 50s to work for a clothing company. She was a college graduate
with 2 children and had recently been separated from her husband. She worked until the …

Before the next normal: How voluntary ESG reporting affects stock performance and trading among publicly-listed companies in the Philippines—An event study

LAP Alcaraz, MAA Calapatia, AIM Joaquin, D Wu - 2022 - animorepository.dlsu.edu.ph
Sustainability is no longer a market niche—it is becoming the new normal. This has led to the
rise of Environmental, Social, and Governance (ESG) reporting spurred by the demand for …